EverSource Wealth Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

EverSource Wealth Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23	Closed	-$16	–	3155
2024 Q2	$16	Hold	23	–	–	﹤0.01%	3049
2024 Q1	$31	Buy	+23	New	+$25	﹤0.01%	2876

Other funds holding BTCY

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PWA

Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

EverSource Wealth Advisors's BTCY Position: Q3 2024 in Review

EverSource Wealth Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 23 shares — an estimated $16 sold.

EverSource Wealth Advisors first reported a position in BTCY in Q1 2024 and held it in 2 quarters. The position peaked at $31 in Q1 2024. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

EverSource Wealth Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
EverSource Wealth Advisors sold 23 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $16.
EverSource Wealth Advisors first reported a position in Biotricity, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
EverSource Wealth Advisors's Biotricity, Inc. Common Stock position peaked at $31 in Q1 2024.
5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on EverSource Wealth Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.